Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by CAMP, A. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CAMP, A. V.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1981 British Society for Rheumatology


research-article

TIAPROFENIC ACID IN THE TREATMENT OF RHEUMATOID ARTHRITIS

A. VIRGINIA CAMP

Rheumatology Department, Wycombe General Hospital High Wycombe, Bucks

Tiaprofenic acid is a new non-steroidal anti-inflammatory agent. Two studies of its use in treating rheumatoid arthritis are reported here. In the first, tiaprofenic acid was compared with phenylbuta-zone in a double-blind cross-over study of 10 weeks' duration. Both drugs were significantly better than placebo and equal in efficacy with each other. The second study was a long-term open trial of tiaprofenic acid in 20 patients. The drug has been well tolerated over periods of up to three years and its effects in reducing the symptoms and signs of rheumatoid arthritis have been maintained. Side-effects were very few in both studies. Gastro-intestinal symptoms were the most frequently reported. One patient developed melaena three years after starting the drug.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.